This installment of Health Care Beat continues our series on the intersection of artificial intelligence and health care, focusing on the legal and compliance challenges that come with rapid innovation. Co-hosts Chris DeMeo and Amanda Genovese welcome Seyfarth attorney Caroline Pieper to explore how AI is reshaping health plan administration — particularly with respect to claims administration — and the regulatory, ethical, and fiduciary considerations organizations must navigate when adopting or hiring service providers that use these tools.

Read the full transcript of the episode here: https://www.seyfarth.com/dir_docs/podcast_transcripts/HCB_Episode53.pdf

This episode of Health Care Beat kicks off a multi-part series exploring the intersection of artificial intelligence, health care, and the evolving legal landscape that organizations must navigate to stay compliant and adaptable. Co-hosts Chris DeMeo and Amanda Genovese are joined by Rachel See, Senior Counsel in Seyfarth’s Washington, DC office.

Together, they examine AI’s transformative impact on health care, from reshaping patient care to revolutionizing operations and decision-making. They also addresses key regulatory challenges, including compliance with FDA, FTC, and HHS guidelines, as well as the complexities of data privacy under HIPAA, GDPR, and state laws. Rachel provides insights into the emerging risks of AI-related litigation and liability, offering practical advice for organizations as they navigate these legal complexities.

Looking ahead, they discuss predictions for AI’s role in health care over the next 5-10 years, explore upcoming legislative trends, and provide strategies for health care organizations and legal teams to proactively prepare for the rapidly evolving future of artificial intelligence.

Read the full transcript of this episode here: https://www.seyfarth.com/dir_docs/podcast_transcripts/HCB_Episode52.pdf

On this episode of Health Care Beat, co-hosts Chris DeMeo and Amanda Genovese are joined by Seyfarth attorneys Elizabeth MacGregor and Galen Sallomi, members of the firm’s California Wage & Hour Group in San Francisco. Elizabeth and Galen discuss recent Private Attorneys General Act (PAGA) reforms and the critical importance of wage and hour audits for California health care employers.

Read the full transcript of today's episode here: https://www.seyfarth.com/dir_docs/podcast_transcripts/HCB_PAGA%26Wage_Hour_Audit_Basics.pdf

Health care professionals face unique risks when it comes to complying with Designated Health Services regulations, and understanding how to mitigate these risks is essential for protecting your organization. On this special 50th episode of Health Care Beat, co-hosts Chris DeMeo and Amanda Genovese are joined by Mike Lu, Chief Operating Officer, and David Way, Chief Executive Officer, of Full Spectrum Healthcare Management Services. The group discusses key legal considerations surrounding Designated Health Services and provides actionable insights on how to navigate these complexities.

On this episode of Health Care Beat, co-hosts Chris DeMeo and Amanda Genovese are joined by Jesse Coleman, a Commercial Litigation partner in Seyfarth’s Houston office and co-chair of the firm’s national Health Care group. Together, they discuss restrictive covenants in the health care sector, some of the unique arguments for and against their use in this field, and recent state and federal efforts to regulate their use.

This episode of Health Care Beat focuses on how employers can best address objections to providing treatment in a health care setting when those objections are based on religious beliefs regarding the requested treatment. Co-hosts Chris DeMeo and Amanda Genovese are joined by Seyfarth partners Karla Grossenbacher, chair of the Washington, DC office’s Labor & Employment practice, and Leon Rodriguez, a member of the DC Labor & Employment practice and the national Health Care Steering Committee, and former director of the Department of Health and Human Services Office for Civil Rights.

In this episode of Health Care Beat, we focus on California joint employment principles as they apply to the health care industry. Co-hosts Chris DeMeo and Amanda Genovese are joined by Bailey Bifoss, a Labor & Employment partner in Seyfarth’s San Francisco office, along with Jeannette Albo, Director & Associate General Counsel of Legal Services at Community Health System. The group discusses what constitutes joint employment, how health care stakeholders are uniquely affected by it, and best practices around potential joint employment claims.

On this episode of Health Care Beat, we continue our multi-part series in collaboration with Seyfarth’s Global Immigration practice. Daniela Mayer, Counsel in the firm’s Boston office, rejoins co-hosts Chris DeMeo and Amanda Genovese, along with Pascal Descargues, Founder and CEO of Genoskin, who makes his first appearance on the podcast. Pascal highlights Genoskin's transformative impact on the biotechnology space, focusing on how its innovative approaches advance clinical research and product development. He also explains how business immigration has played an important role in shaping the company’s strategy.

On this episode of Health Care Beat, co-hosts Chris DeMeo and Amanda Genovese are joined by Logan Geen, Corporate Counsel of Managed Care Contracting at Lehigh Valley Health Network. Logan shares his career journey and highlights some of the challenges he has faced as corporate counsel for a large health care system. He also provides practical advice to recent law school graduates considering a path in the health care sector.

This episode of Health Care Beat kicks off a two-part series in collaboration with Seyfarth’s Global Immigration practice. Co-hosts Chris DeMeo and Amanda Genovese are joined by Daniela Mayer, Counsel in the firm’s Boston office, as well as Fred Chereau, Senior Vice President of Strategy and Business Development at Alexion Pharmaceuticals. The group discusses Fred’s career trajectory and the value of leveraging immigration programs to secure talent in the health care, life sciences, and pharmaceutical industries.